Prostate Cancer Specification
0.1.0 - ci-build

Prostate Cancer Specification - Local Development build (v0.1.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

Example QuestionnaireResponse: QuestionnaireResponse - Core Needle Biopsy Case Level

LinkIDTextDefinitionAnswerdoco
QuestionnaireResponseCoreNeedleBiopsyCaseQuestionnaire:https://art-decor.org/fhir/Questionnaire/2.16.840.1.113883.3.1937.777.18.27.18--20250115134435
QuestionnaireResponseCoreNeedleBiopsyCase / 2.16.840.1.113883.3.1937.777.18.2.4.10000Prostatakarzinome
QuestionnaireResponseCoreNeedleBiopsyCase / 2.16.840.1.113883.3.1937.777.18.2.4.10000 / 2.16.840.1.113883.3.1937.777.18.2.83Patientendaten
QuestionnaireResponseCoreNeedleBiopsyCase / 2.16.840.1.113883.3.1937.777.18.2.4.10000 / 2.16.840.1.113883.3.1937.777.18.2.83 / 2.16.840.1.113883.3.1937.777.18.2.84FamiliennameMueller
QuestionnaireResponseCoreNeedleBiopsyCase / 2.16.840.1.113883.3.1937.777.18.2.4.10000 / 2.16.840.1.113883.3.1937.777.18.2.83 / 2.16.840.1.113883.3.1937.777.18.2.85VornameHans
QuestionnaireResponseCoreNeedleBiopsyCase / 2.16.840.1.113883.3.1937.777.18.2.4.10000 / 2.16.840.1.113883.3.1937.777.18.2.83 / 2.16.840.1.113883.3.1937.777.18.2.86Geburtsdatum1955-08-15
QuestionnaireResponseCoreNeedleBiopsyCase / 2.16.840.1.113883.3.1937.777.18.2.4.10000 / 2.16.840.1.113883.3.1937.777.18.2.83 / 2.16.840.1.113883.3.1937.777.18.2.87Patienten-IdentifikatorPAT-2024-001
QuestionnaireResponseCoreNeedleBiopsyCase / 2.16.840.1.113883.3.1937.777.18.2.4.10000 / 2.16.840.1.113883.3.1937.777.18.2.83 / 2.16.840.1.113883.3.1937.777.18.2.88Auftragsnummer des EinsendersPATH-RPT-2024-001
QuestionnaireResponseCoreNeedleBiopsyCase / 2.16.840.1.113883.3.1937.777.18.2.4.10000 / 2.16.840.1.113883.3.1937.777.18.2.83 / 2.16.840.1.113883.3.1937.777.18.2.89Eingangs-/FallnummerE_24_001
QuestionnaireResponseCoreNeedleBiopsyCase / 2.16.840.1.113883.3.1937.777.18.2.4.10000 / 2.16.840.1.113883.3.1937.777.18.2.4.10210Stanzbiopsien
QuestionnaireResponseCoreNeedleBiopsyCase / 2.16.840.1.113883.3.1937.777.18.2.4.10000 / 2.16.840.1.113883.3.1937.777.18.2.4.10210 / 2.16.840.1.113883.3.1937.777.18.2.4.11249Diagnostische Schlussfolgerung
QuestionnaireResponseCoreNeedleBiopsyCase / 2.16.840.1.113883.3.1937.777.18.2.4.10000 / 2.16.840.1.113883.3.1937.777.18.2.4.10210 / 2.16.840.1.113883.3.1937.777.18.2.4.11249 / 2.16.840.1.113883.3.1937.777.18.2.52Histologischer Typ ICD-O-3unknown: 8140/3 (Azinäres Adenokarzinom)
QuestionnaireResponseCoreNeedleBiopsyCase / 2.16.840.1.113883.3.1937.777.18.2.4.10000 / 2.16.840.1.113883.3.1937.777.18.2.4.10210 / 2.16.840.1.113883.3.1937.777.18.2.4.11249 / 2.16.840.1.113883.3.1937.777.18.2.50Morphologie FreitextKonventionelles Adenokarzinom der Prostata mit prominenten azidophilen Nukleolen
QuestionnaireResponseCoreNeedleBiopsyCase / 2.16.840.1.113883.3.1937.777.18.2.4.10000 / 2.16.840.1.113883.3.1937.777.18.2.4.10210 / 2.16.840.1.113883.3.1937.777.18.2.4.11249 / 2.16.840.1.113883.3.1937.777.18.2.4.11247ICD-O Versionunknown: 33 (ICD-O-3 2. Auflage 2019)
QuestionnaireResponseCoreNeedleBiopsyCase / 2.16.840.1.113883.3.1937.777.18.2.4.10000 / 2.16.840.1.113883.3.1937.777.18.2.4.10210 / 2.16.840.1.113883.3.1937.777.18.2.4.11249 / 2.16.840.1.113883.3.1937.777.18.2.4.11205Histologischer Grad
QuestionnaireResponseCoreNeedleBiopsyCase / 2.16.840.1.113883.3.1937.777.18.2.4.10000 / 2.16.840.1.113883.3.1937.777.18.2.4.10210 / 2.16.840.1.113883.3.1937.777.18.2.4.11249 / 2.16.840.1.113883.3.1937.777.18.2.4.11205 / 2.16.840.1.113883.3.1937.777.18.2.66Höchster Grad
QuestionnaireResponseCoreNeedleBiopsyCase / 2.16.840.1.113883.3.1937.777.18.2.4.10000 / 2.16.840.1.113883.3.1937.777.18.2.4.10210 / 2.16.840.1.113883.3.1937.777.18.2.4.11249 / 2.16.840.1.113883.3.1937.777.18.2.4.11205 / 2.16.840.1.113883.3.1937.777.18.2.66 / 2.16.840.1.113883.3.1937.777.18.2.69BiopsietypSNOMED CT: 40013009 (Core needle biopsy of prostate)
QuestionnaireResponseCoreNeedleBiopsyCase / 2.16.840.1.113883.3.1937.777.18.2.4.10000 / 2.16.840.1.113883.3.1937.777.18.2.4.10210 / 2.16.840.1.113883.3.1937.777.18.2.4.11249 / 2.16.840.1.113883.3.1937.777.18.2.4.11205 / 2.16.840.1.113883.3.1937.777.18.2.66 / 2.16.840.1.113883.3.1937.777.18.2.38Primäres Gleason MusterSNOMED CT: 369772003 (Gleason Pattern 3 (finding))
QuestionnaireResponseCoreNeedleBiopsyCase / 2.16.840.1.113883.3.1937.777.18.2.4.10000 / 2.16.840.1.113883.3.1937.777.18.2.4.10210 / 2.16.840.1.113883.3.1937.777.18.2.4.11249 / 2.16.840.1.113883.3.1937.777.18.2.4.11205 / 2.16.840.1.113883.3.1937.777.18.2.66 / 2.16.840.1.113883.3.1937.777.18.2.39Sekundäres Gleason MusterSNOMED CT: 369773008 (Gleason Pattern 4 (finding))
QuestionnaireResponseCoreNeedleBiopsyCase / 2.16.840.1.113883.3.1937.777.18.2.4.10000 / 2.16.840.1.113883.3.1937.777.18.2.4.10210 / 2.16.840.1.113883.3.1937.777.18.2.4.11249 / 2.16.840.1.113883.3.1937.777.18.2.4.11205 / 2.16.840.1.113883.3.1937.777.18.2.66 / 2.16.840.1.113883.3.1937.777.18.2.4.10270Grade Group (ISUP 2014 / WHO 2016)SNOMED CT: 1279714001 (International Society of Urological Pathology grade group 2 (Gleason score 3 + 4 = 7) (qualifier value))
QuestionnaireResponseCoreNeedleBiopsyCase / 2.16.840.1.113883.3.1937.777.18.2.4.10000 / 2.16.840.1.113883.3.1937.777.18.2.4.10210 / 2.16.840.1.113883.3.1937.777.18.2.4.11249 / 2.16.840.1.113883.3.1937.777.18.2.4.11205 / 2.16.840.1.113883.3.1937.777.18.2.66 / 2.16.840.1.113883.3.1937.777.18.2.67Prozentualer Anteil Gleasonmuster 477 % (Details: UCUM code% = '%')
QuestionnaireResponseCoreNeedleBiopsyCase / 2.16.840.1.113883.3.1937.777.18.2.4.10000 / 2.16.840.1.113883.3.1937.777.18.2.4.10210 / 2.16.840.1.113883.3.1937.777.18.2.4.11249 / 2.16.840.1.113883.3.1937.777.18.2.76Spezielle Wachstumsmuster
QuestionnaireResponseCoreNeedleBiopsyCase / 2.16.840.1.113883.3.1937.777.18.2.4.10000 / 2.16.840.1.113883.3.1937.777.18.2.4.10210 / 2.16.840.1.113883.3.1937.777.18.2.4.11249 / 2.16.840.1.113883.3.1937.777.18.2.76 / 2.16.840.1.113883.3.1937.777.18.2.77IDC-P und/oder ICCSNOMED CT: 47492008 (Not seen (qualifier value))
QuestionnaireResponseCoreNeedleBiopsyCase / 2.16.840.1.113883.3.1937.777.18.2.4.10000 / 2.16.840.1.113883.3.1937.777.18.2.4.10210 / 2.16.840.1.113883.3.1937.777.18.2.4.11249 / 2.16.840.1.113883.3.1937.777.18.2.4.11232Tumorausbreitung
QuestionnaireResponseCoreNeedleBiopsyCase / 2.16.840.1.113883.3.1937.777.18.2.4.10000 / 2.16.840.1.113883.3.1937.777.18.2.4.10210 / 2.16.840.1.113883.3.1937.777.18.2.4.11249 / 2.16.840.1.113883.3.1937.777.18.2.4.11232 / 2.16.840.1.113883.3.1937.777.18.2.80BiopsietypSystematische Biopsie
QuestionnaireResponseCoreNeedleBiopsyCase / 2.16.840.1.113883.3.1937.777.18.2.4.10000 / 2.16.840.1.113883.3.1937.777.18.2.4.10210 / 2.16.840.1.113883.3.1937.777.18.2.4.11249 / 2.16.840.1.113883.3.1937.777.18.2.4.11232 / 2.16.840.1.113883.3.1937.777.18.2.4.10320Verhältnis positiver zu allen Stanzen7/12
QuestionnaireResponseCoreNeedleBiopsyCase / 2.16.840.1.113883.3.1937.777.18.2.4.10000 / 2.16.840.1.113883.3.1937.777.18.2.4.10210 / 2.16.840.1.113883.3.1937.777.18.2.4.11249 / 2.16.840.1.113883.3.1937.777.18.2.4.11232 / 2.16.840.1.113883.3.1937.777.18.2.2.11142Prozentualer Tumoranteil Gesamt35 % (Details: UCUM code% = '%')
QuestionnaireResponseCoreNeedleBiopsyCase / 2.16.840.1.113883.3.1937.777.18.2.4.10000 / 2.16.840.1.113883.3.1937.777.18.2.4.10210 / 2.16.840.1.113883.3.1937.777.18.2.4.11249 / 2.16.840.1.113883.3.1937.777.18.2.4.11232 / 2.16.840.1.113883.3.1937.777.18.2.4.11204Tumorbefall Gesamt in Länge in mm18.5 mm (Details: UCUM codemm = 'mm')
QuestionnaireResponseCoreNeedleBiopsyCase / 2.16.840.1.113883.3.1937.777.18.2.4.10000 / 2.16.840.1.113883.3.1937.777.18.2.4.10210 / 2.16.840.1.113883.3.1937.777.18.2.4.11249 / 2.16.840.1.113883.3.1937.777.18.2.34Extraprostatische AusbreitungSNOMED CT: 52101004 (Present (qualifier value))
QuestionnaireResponseCoreNeedleBiopsyCase / 2.16.840.1.113883.3.1937.777.18.2.4.10000 / 2.16.840.1.113883.3.1937.777.18.2.4.10210 / 2.16.840.1.113883.3.1937.777.18.2.4.11249 / 2.16.840.1.113883.3.1937.777.18.2.4.11241Lokalisation Extraprostatische TumorausbreitungLOINC: LA25151-4 (Apical)
QuestionnaireResponseCoreNeedleBiopsyCase / 2.16.840.1.113883.3.1937.777.18.2.4.10000 / 2.16.840.1.113883.3.1937.777.18.2.4.10210 / 2.16.840.1.113883.3.1937.777.18.2.4.11249 / 2.16.840.1.113883.3.1937.777.18.2.32Tumornachweis in SamenblasenSNOMED CT: 47492008 (Not seen (qualifier value))
QuestionnaireResponseCoreNeedleBiopsyCase / 2.16.840.1.113883.3.1937.777.18.2.4.10000 / 2.16.840.1.113883.3.1937.777.18.2.4.10210 / 2.16.840.1.113883.3.1937.777.18.2.4.11249 / 2.16.840.1.113883.3.1937.777.18.2.33Lymphovaskuläre InvasionSNOMED CT: 47492008 (Not seen (qualifier value))
QuestionnaireResponseCoreNeedleBiopsyCase / 2.16.840.1.113883.3.1937.777.18.2.4.10000 / 2.16.840.1.113883.3.1937.777.18.2.4.10210 / 2.16.840.1.113883.3.1937.777.18.2.4.11249 / 2.16.840.1.113883.3.1937.777.18.2.31Perineurale InfiltrationSNOMED CT: 52101004 (Present (qualifier value))
QuestionnaireResponseCoreNeedleBiopsyCase / 2.16.840.1.113883.3.1937.777.18.2.4.10000 / 2.16.840.1.113883.3.1937.777.18.2.4.10210 / 2.16.840.1.113883.3.1937.777.18.2.4.11249 / 2.16.840.1.113883.3.1937.777.18.2.4.11207Intraduktales KarzinomSNOMED CT: 47492008 (Not seen (qualifier value))
QuestionnaireResponseCoreNeedleBiopsyCase / 2.16.840.1.113883.3.1937.777.18.2.4.10000 / 2.16.840.1.113883.3.1937.777.18.2.4.10210 / 2.16.840.1.113883.3.1937.777.18.2.4.11249 / 2.16.840.1.113883.3.1937.777.18.2.35ASAP (Atypical Small Acinar Proliferation)SNOMED CT: 373067005 (No (qualifier value))
QuestionnaireResponseCoreNeedleBiopsyCase / 2.16.840.1.113883.3.1937.777.18.2.4.10000 / 2.16.840.1.113883.3.1937.777.18.2.4.10210 / 2.16.840.1.113883.3.1937.777.18.2.4.11249 / 2.16.840.1.113883.3.1937.777.18.2.36Begleitende High-grade-PINSNOMED CT: 47492008 (Not seen (qualifier value))
QuestionnaireResponseCoreNeedleBiopsyCase / 2.16.840.1.113883.3.1937.777.18.2.4.10000 / 2.16.840.1.113883.3.1937.777.18.2.4.10210 / 2.16.840.1.113883.3.1937.777.18.2.4.11249 / 2.16.840.1.113883.3.1937.777.18.2.37Granulomatöse ProstatitisSNOMED CT: 47492008 (Not seen (qualifier value))

doco Documentation for this format